Johnson & Johnson said on Tuesday it struck a deal to buy heart pump maker Abiomed Inc. for $16.6 billion in cash, as it looks to boost growth at its medical devices unit after next year’s planned spinoff of its consumer health business.
Tag Archive for: Joaquin Duato
2022 has been marked by the first year of leadership under CEO Joaquin Duato and the anticipated separation of the company’s consumer health business.